|
E-mail this page to a friend!
Women's Health Study
Vitamin E Not Recommended for Older Women to Protect
Heart or Prevent Cancer
July 6, 2005 – While advocates and manufacturers of
Vitamin E hailed a new study as proof that Vitamin E is safe and lowers
the risk of cardiovascular death for older, healthy women, the authors
of this large study say the report “does not support recommending
vitamin E supplementation for CVD or cancer prevention among healthy
women.”
| |
Related Story |
|
| |
Women's Health Study
Vitamin E Is Safe and Shows Big Reduction in Heart
Risk for Older Women
Largest study ever says cardiovascular deaths
declined for boomers 24%, seniors 49%
July 5, 2005 - The Women's Health Study, to be
published tomorrow in the Journal of the American Medical
Association (JAMA), found 600IU vitamin E is safe and significantly
reduces the risk of cardiovascular death in older, healthy women.
Read more...
|
|
In an an article in this week’s JAMA, I-Min Lee,
M.B.B.S., Sc.D., of Brigham and Women’s Hospital and Harvard Medical
School, Boston, and colleagues analyzed data from the vitamin E
component of the Women’s Health Study, which tested whether vitamin E
supplementation decreases the risk of cardiovascular disease and cancer
among healthy women.
According to background information in the article,
previous observational studies have indicated that vitamin E may be
beneficial in lowering the risk for some cardiovascular diseases; and
high antioxidant intake has been linked to reduced cancer rates.
For small to moderate effects, however, the amount
of uncontrolled and uncontrollable confounding inherent in observational
studies can be as large as the postulated benefit, so randomized
clinical trials represent the most reliable study design strategy.
Randomized trials do not generally support benefits
of vitamin E, but there are few trials of long duration among initially
healthy persons.
By 1997, despite a lack of randomized trials, 44
percent of U.S. cardiologists reported routine use of antioxidant
supplements, primarily vitamin E, compared with 42 percent who routinely
used aspirin for the primary prevention of CVD.
In this component of the Women’s Health Study,
39,876 apparently healthy U.S. women aged at least 45 years were
randomly assigned to receive 600 IU of natural-source vitamin E on
alternate days or placebo, and were followed up for an average of 10.1
years.
The researchers found with the vitamin E group,
there was no significant effect on major cardiovascular events, on the
incidences of heart attack or stroke, as well as ischemic or hemorrhagic
stroke. They did find that for cardiovascular death, there was a 24
percent reduction.
There was no significant effect on the incidences
of total cancer or breast, lung, or colon cancers. Cancer deaths also
did not differ significantly between groups. There was no significant
effect of vitamin E on total death.
“In conclusion, the WHS does not support
recommending vitamin E supplementation for CVD or cancer prevention
among healthy women. This large trial supports current guidelines
stating that use of antioxidant vitamins is not justified for CVD risk
reduction,” the authors say.
“The WHS findings should be viewed in the context
of the available randomized evidence, as well as data that should be
available over the next several years from ongoing trials, including the
Physicians’ Health Study, which will provide data on primary prevention
in men. At present, in the primary prevention of CVD and cancer,
therapeutic lifestyle changes including a healthy diet and control of
major risk factors remain important clinical and public health
strategies,” the authors conclude.
In an accompanying editorial, Rita F. Redberg,
M.D., M.Sc., of the University of California, San Francisco, wrote,
“Perhaps it is time to consider devoting some of the limited resources
necessary to perform randomized controlled trials to other pressing,
unanswered questions in the field of cardiovascular disease prevention
in women. With the publication of the WHS vitamin E results, it is time
to redirect attention to interventions that have been shown to or could
provide significant benefit.”
“Vitamin E enters the category of therapies that
were promising in epidemiologic and observational studies but failed to
deliver in adequately powered randomized controlled trials,” according
to Redberg.
“As in other studies, the ‘healthy user’ bias must
be considered, i.e., the healthy lifestyle behaviors that characterize
individuals who care enough about their health to take various
supplements are actually responsible for the better health, but this is
minimized with the rigorous trial design. It is estimated that almost 1
million preventable deaths per year are due to smoking, poor diet, and
physical inactivity. Perhaps the most important outcome of the WHS
reports will be greater recognition that it is time to concentrate on
teaching nutrition, promoting regular physical activity, and strongly
encouraging smoking cessation and particularly increasing outreach to
women of racial and ethnic minorities,” Dr. Redberg writes. “[These] are
underused but proven prevention strategies for heart disease.
Interestingly, these positive lifestyle changes are also associated with
the prevention of cancer and Alzheimer disease.”
Click to More Senior News on the
Front Page
Copyright: SeniorJournal.com |